Nxera Pharma UK Ltd: controlled_by
| Value | {"lei": "2138004M62BFNJMR2Z82", "meaning": "oberste Konsolidierung (Konzernspitze)", "entity_ref": "bea7ec2b-19bd-4955-8f57-fdeead59b91c", "relationship_type": "IS_ULTIMATELY_CONSOLIDATED_BY"} |
|---|---|
| Period | 2025-12-31 |
| Status | current |
| Entity | Nxera Pharma UK Ltd |
Provenance
Source: GLEIF LEI Golden Copy (CC0-1.0)
Reference:
Retrieved: 2026-08-19T10:26:40.718914+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/fccdb24e-882f-4db6-9fc2-500fcdc83d8e
Source: GLEIF LEI Golden Copy (CC0-1.0)
Reference:
894500BZ9XDN44SZ8Y70->2138004M62BFNJMR2Z82:IS_ULTIMATELY_CONSOLIDATED_BYRetrieved: 2026-08-19T10:26:40.718914+02:00
Raw response sha256:
961b486f0dbecd62ee3a9608f1c8ee5e…Cite as: FACTANKER, https://factanker.com/fact/fccdb24e-882f-4db6-9fc2-500fcdc83d8e
History
- supersedes {"lei": "2138004M62BFNJMR2Z82", "meaning": "direkte Konsolidierung (Mutter)", "entity_ref": "bea7ec2b-19bd-4955-8f57-fdeead59b91c", "relationship_type": "IS_DIRECTLY_CONSOLIDATED_BY"} (evidence 894500BZ9XDN44SZ8Y70->2138004M62BFNJMR2Z82:IS_DIRECTLY_CONSOLIDATED_BY)